Noji S - Search Results

1

A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.

Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M. Tamura R, et al. Among authors: noji s. Nat Commun. 2019 Dec 17;10(1):5758. doi: 10.1038/s41467-019-13640-1. Nat Commun. 2019. PMID: 31848332 Free PMC article. Clinical Trial.

2

[Biomarkers for cancer immunotherapy].

Kawakami Y, Kawase Y, Ohizumi A, Noji S, Sakurai T, Fujita T. Kawakami Y, et al. Among authors: noji s. Nihon Rinsho. 2012 May;70(5):759-66. Nihon Rinsho. 2012. PMID: 22619998 Review. Japanese.

3

Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.

Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y. Okabayashi K, et al. Among authors: noji s. Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16. Cancer Sci. 2012. PMID: 22676270 Free PMC article.

4

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.

Kinoshita T, Kudo-Saito C, Muramatsu R, Fujita T, Saito M, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Hayashi Y, Kaseda K, Kamiyama I, Ohtsuka T, Tomizawa K, Shimoji M, Mitsudomi T, Asamura H, Kawakami Y. Kinoshita T, et al. Among authors: noji s. Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23. Eur J Cancer. 2017. PMID: 28950145

5

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.

Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Shibao S, et al. Among authors: noji s. Oncotarget. 2018 Apr 20;9(30):21569-21579. doi: 10.18632/oncotarget.25131. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765561 Free PMC article.

6

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma.

Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Kikuchi R, et al. Among authors: noji s. J Clin Med. 2019 Feb 20;8(2):263. doi: 10.3390/jcm8020263. J Clin Med. 2019. PMID: 30791546 Free PMC article.

7

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series.

Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Hikichi T, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. Tamura R, et al. Among authors: noji s. BMC Cancer. 2020 Mar 12;20(1):196. doi: 10.1186/s12885-020-6589-x. BMC Cancer. 2020. PMID: 32164575 Free PMC article. Clinical Trial.

8

Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series.

Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Hikichi T, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. Tamura R, et al. Among authors: noji s. BMC Cancer. 2020 Apr 14;20(1):301. doi: 10.1186/s12885-020-06783-8. BMC Cancer. 2020. PMID: 32290821 Free PMC article.

9

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.

Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M. Tamura R, et al. Among authors: noji s. Nat Commun. 2020 Apr 21;11(1):2028. doi: 10.1038/s41467-020-16007-z. Nat Commun. 2020. PMID: 32317644 Free PMC article.

10

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, Noji S, Yaguchi T, Iwata T, Ohta S, Fujita T, Tanosaki R, Handa M, Okamoto S, Amagai M, Kawakami Y. Hirai I, et al. Among authors: noji s. Cancer Sci. 2021 Aug;112(8):3163-3172. doi: 10.1111/cas.15009. Epub 2021 Jun 30. Cancer Sci. 2021. PMID: 34101300 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page